MDXH — MDxHealth SA Cashflow Statement
0.000.00%
- $76.41m
- $103.01m
- $70.19m
- 56
- 47
- 45
- 47
Annual cashflow statement for MDxHealth SA, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | C2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -43.2 | -27.1 | -26.8 | -37.9 | -27.3 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 7.16 | 1.57 | 1.22 | 0.911 | 0.665 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 10.3 | 1.98 | 0.035 | -2.04 | -1.69 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -22.3 | -20.2 | -22.5 | -34.1 | -21.5 |
Capital Expenditures | -0.073 | -0.537 | -0.896 | -4.16 | -5.02 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | — | — | 0 | -25 | 1.09 |
Acquisition of Business | |||||
Sale of Business | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -0.073 | -0.537 | -0.896 | -29.2 | -3.93 |
Financing Cash Flow Items | -0.324 | -1.07 | -1 | -1.29 | -4.05 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 18 | 14.3 | 66.5 | 20.8 | 32.3 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -4.15 | -6.1 | 42.5 | -43 | 6.88 |